Incyte | Capital Ordinaire

Prix De L'Action
102.96
Variation Quotidienne
2.04 2.02%
Mensuellement
1.15%
Annuel
36.81%
Q1 Prévisions
96.99




Capital Ordinaire Changement Date
Acadia Pharmaceuticals USD 168.71M 104K 2025-09
Agios Pharmaceuticals USD 58.28M 241K 2025-09
Alnylam Pharmaceuticals USD 131.79M 130.49M 2025-09
Amgen USD 538M 300K 2025-09
Biogen USD 146.7M 200K 2025-09
BioMarin Pharmaceutical USD 192.1M 97K 2025-09
Bristol-Myers Squibb USD 2.04B 1.74B 2025-09
Eli Lilly USD 946.83M 354.23M 2025-06
Exelixis USD 268.1M 2.03M 2025-09
Gilead Sciences USD 1.24B 0 2025-09
Incyte USD 196.13M 2.01M 2025-09
Ionis Pharmaceuticals USD 161.14M 160.98M 2025-09
MacroGenics USD 63.26M 62.63M 2025-09
Merck USD 2.49B 15.79M 2025-09
Moderna USD 391M 2M 2025-09
Neurocrine Biosciences USD 99.7M 700K 2025-09
Novartis USD 1.94B 23.4M 2025-06
Novartis USD 1.92B 17.06M 2025-09
Pfizer USD 5.69B 1000K 2025-09
PTC Therapeutics USD 79.93M 554K 2025-09
Regeneron Pharmaceuticals USD 105.3M 1.1M 2025-09
Sarepta Therapeutics USD 104.77M 7.06M 2025-09
Ultragenyx Pharmaceutical USD 96.44M 88K 2025-09
Vertex Pharmaceuticals USD 254M 2.29M 2025-09


Incyte Capital Ordinaire - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Feb 2026.